Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMAGINE 6: LY2605541 vs human insulin NPH in insulin‑naive type 2 diabetes
KCT0000801Phase 3Recruiting
- Sponsor
- Eli Lilly and Company
- Start
- May 2013
- Modality
- Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of insulin peglispro in type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Started May 2013; status: recruiting.
02
Drugs
insulin peglispro
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on KCT0000801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000801.